Scholars Central

EditorialPublished 2021

Pseudoprogression under checkpoint inhibition therapy

Authors: Mona Passler Department of Gynecology, Competence Center for Ovarian Cancer (EKZE), Charité - University Medicine, Berlin, Germany

Acta Psychopathologica

Volume 7 · Issue 8

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

A novel agent called checkpoint inhibitor therapy has revolutionized not only the treatment for several tumor entities but also our general understanding of oncology. As more and more patients with solid tumors undergo this promising immune therapy, new phenomena like pseudoprogression challenge the clinician. Pseudoprogression is a temporary increase in tumor size due to infiltrating leucocytes and edema during checkpoint inhibitor therapy, which can be mistaken with real progression. Subsequently, tumor size decreases due to tumor cell destruction. Pseudoprogression is described in 1,5% - 17% of all cases - depending on the tumor entity and study. Identifying pseudoprogression plays a decisive part in successfully using checkpoint inhibition therapy, because the misinterpretation of tumor growth might lead to the discontinuation of an effective treatment, as pseudoprogression indicates a high likelihood of > 1year survival. In order to guarantee the best possible treatment, it is crucial to be informed about pseudoprogression and to know techniques to distinguish between pseudo- and real progression when tumor size increases under checkpoint inhibition therapy. While there are several indicators to differentiate between the two, ultimately only infiltrating growth – which solely occurs in malign tumor growth – proves real progression.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Similar by topic

More from this journal

The newest in Acta Psychopathologica.

All its articles

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalActa Psychopathologica
  • BylineArticles whose byline prints “Mona Passler Department of Gynecology”
  • BylineArticles whose byline prints “Competence Center for Ovarian Cancer (EKZE)”
  • BylineArticles whose byline prints “Charité - University Medicine”
  • BylineArticles whose byline prints “Berlin”
  • BylineArticles whose byline prints “Germany”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels